Sandhill Capital Partners’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.41M	Hold	18,072	–	–	0.1%	53
2025 Q1	$1.31M	Sell	18,072 -2,400	-12%	-$174K	0.11%	55
2024 Q4	$1.52M	Hold	20,472	–	–	0.12%	56
2024 Q3	$1.35M	Hold	20,472	–	–	0.1%	57
2024 Q2	$1.89M	Hold	20,472	–	–	0.15%	55
2024 Q1	$1.96M	Sell	20,472 -4,500	-18%	-$430K	0.16%	52
2023 Q4	$1.9M	Buy	24,972 +900	+4%	+$68.6K	0.16%	52
2023 Q3	$1.67M	Hold	24,072	–	–	0.16%	57
2023 Q2	$2.27M	Hold	24,072	–	–	0.21%	53
2023 Q1	$1.99M	Hold	24,072	–	–	0.19%	55
2022 Q4	$1.8M	Hold	24,072	–	–	0.19%	57
2022 Q3	$1.99M	Sell	24,072 -12,000	-33%	-$992K	0.23%	57
2022 Q2	$3.43M	Buy	36,072 +10,000	+38%	+$951K	0.37%	55
2022 Q1	$3.07M	Sell	26,072 -1,000	-4%	-$118K	0.26%	35
2021 Q4	$3.51M	Sell	27,072 -1,000	-4%	-$130K	0.27%	34
2021 Q3	$3.18M	Sell	28,072 -1,000	-3%	-$113K	0.25%	33
2021 Q2	$3.01M	Sell	29,072 -940	-3%	-$97.4K	0.23%	34
2021 Q1	$2.51M	Buy	30,012 +12	+0%	+$1K	0.21%	36
2020 Q4	$2.74M	Sell	30,000 -7	-0%	-$639	0.25%	37
2020 Q3	$2.4M	Buy	30,007 +7	+0%	+$559	0.24%	40
2020 Q2	$2.07M	Hold	30,000	–	–	0.24%	38
2020 Q1	$1.89M	Sell	30,000 -120	-0.4%	-$7.54K	0.25%	41
2019 Q4	$2.34M	Buy	30,120 +120	+0.4%	+$9.33K	0.26%	36
2019 Q3	$2.2M	Buy	+30,000	New	+$2.2M	0.27%	35
2013 Q4	–	Sell	-659,892	Closed	-$7.66M	–	84
2013 Q3	$7.66M	Buy	659,892 +19,134	+3%	+$222K	3.44%	16
2013 Q2	$7.18M	Buy	+640,758	New	+$7.18M	3.55%	13